The manufacturing agreement is the second by Medicines Patent Pool aiming to boost supplies of a pill to prevent Covid-19 infections from turning severe.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.